This review discusses the characteristics, current status, and precautions for using novel oral anticoagulants to prevent cardiogenic cerebral embolism in patients with atrial fibrillation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ago et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: